nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.591	1	CbGbCtD
Doxylamine—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.00251	0.181	CrCbGaD
Doxylamine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.0037	CcSEcCtD
Doxylamine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00369	CcSEcCtD
Doxylamine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00144	0.00364	CcSEcCtD
Doxylamine—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00363	CcSEcCtD
Doxylamine—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00363	CcSEcCtD
Doxylamine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00143	0.00362	CcSEcCtD
Doxylamine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.0036	CcSEcCtD
Doxylamine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00142	0.0036	CcSEcCtD
Doxylamine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00142	0.0036	CcSEcCtD
Doxylamine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00358	CcSEcCtD
Doxylamine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00357	CcSEcCtD
Doxylamine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.0014	0.00355	CcSEcCtD
Doxylamine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00353	CcSEcCtD
Doxylamine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.00352	CcSEcCtD
Doxylamine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.0035	CcSEcCtD
Doxylamine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00135	0.00343	CcSEcCtD
Doxylamine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00343	CcSEcCtD
Doxylamine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00341	CcSEcCtD
Doxylamine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00341	CcSEcCtD
Doxylamine—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00134	0.0034	CcSEcCtD
Doxylamine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.0034	CcSEcCtD
Doxylamine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.0034	CcSEcCtD
Doxylamine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00336	CcSEcCtD
Doxylamine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.00335	CcSEcCtD
Doxylamine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00334	CcSEcCtD
Doxylamine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00332	CcSEcCtD
Doxylamine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00332	CcSEcCtD
Doxylamine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00331	CcSEcCtD
Doxylamine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00331	CcSEcCtD
Doxylamine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.0033	CcSEcCtD
Doxylamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.00327	CcSEcCtD
Doxylamine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00327	CcSEcCtD
Doxylamine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00325	CcSEcCtD
Doxylamine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00324	CcSEcCtD
Doxylamine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00324	CcSEcCtD
Doxylamine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00324	CcSEcCtD
Doxylamine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00322	CcSEcCtD
Doxylamine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00322	CcSEcCtD
Doxylamine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.0032	CcSEcCtD
Doxylamine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00317	CcSEcCtD
Doxylamine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00316	CcSEcCtD
Doxylamine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00313	CcSEcCtD
Doxylamine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00313	CcSEcCtD
Doxylamine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.0031	CcSEcCtD
Doxylamine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00307	CcSEcCtD
Doxylamine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00307	CcSEcCtD
Doxylamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.00305	CcSEcCtD
Doxylamine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00301	CcSEcCtD
Doxylamine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.003	CcSEcCtD
Doxylamine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00118	0.003	CcSEcCtD
Doxylamine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00118	0.00298	CcSEcCtD
Doxylamine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00297	CcSEcCtD
Doxylamine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00297	CcSEcCtD
Doxylamine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00294	CcSEcCtD
Doxylamine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00294	CcSEcCtD
Doxylamine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00293	CcSEcCtD
Doxylamine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00293	CcSEcCtD
Doxylamine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00292	CcSEcCtD
Doxylamine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00292	CcSEcCtD
Doxylamine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.0029	CcSEcCtD
Doxylamine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00288	CcSEcCtD
Doxylamine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00288	CcSEcCtD
Doxylamine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00288	CcSEcCtD
Doxylamine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00286	CcSEcCtD
Doxylamine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00283	CcSEcCtD
Doxylamine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00283	CcSEcCtD
Doxylamine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00283	CcSEcCtD
Doxylamine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00283	CcSEcCtD
Doxylamine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.0028	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00279	CcSEcCtD
Doxylamine—Toremifene—CYP1A1—chronic obstructive pulmonary disease	0.0011	0.0792	CrCbGaD
Doxylamine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00278	CcSEcCtD
Doxylamine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00277	CcSEcCtD
Doxylamine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00277	CcSEcCtD
Doxylamine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00276	CcSEcCtD
Doxylamine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00272	CcSEcCtD
Doxylamine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00272	CcSEcCtD
Doxylamine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00272	CcSEcCtD
Doxylamine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00271	CcSEcCtD
Doxylamine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00271	CcSEcCtD
Doxylamine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00271	CcSEcCtD
Doxylamine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00271	CcSEcCtD
Doxylamine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00269	CcSEcCtD
Doxylamine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00269	CcSEcCtD
Doxylamine—Toremifene—CYP1A2—chronic obstructive pulmonary disease	0.00106	0.0764	CrCbGaD
Doxylamine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00267	CcSEcCtD
Doxylamine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00266	CcSEcCtD
Doxylamine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00266	CcSEcCtD
Doxylamine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00266	CcSEcCtD
Doxylamine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00261	CcSEcCtD
Doxylamine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00261	CcSEcCtD
Doxylamine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00257	CcSEcCtD
Doxylamine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00256	CcSEcCtD
Doxylamine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00256	CcSEcCtD
Doxylamine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00256	CcSEcCtD
Doxylamine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00256	CcSEcCtD
Doxylamine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00255	CcSEcCtD
Doxylamine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00255	CcSEcCtD
Doxylamine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00254	CcSEcCtD
Doxylamine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000998	0.00253	CcSEcCtD
Doxylamine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000993	0.00251	CcSEcCtD
Doxylamine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000991	0.00251	CcSEcCtD
Doxylamine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000989	0.0025	CcSEcCtD
Doxylamine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000974	0.00246	CcSEcCtD
Doxylamine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000964	0.00244	CcSEcCtD
Doxylamine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000964	0.00244	CcSEcCtD
Doxylamine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000963	0.00244	CcSEcCtD
Doxylamine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000959	0.00243	CcSEcCtD
Doxylamine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000957	0.00242	CcSEcCtD
Doxylamine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000955	0.00242	CcSEcCtD
Doxylamine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00095	0.00241	CcSEcCtD
Doxylamine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000941	0.00238	CcSEcCtD
Doxylamine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000941	0.00238	CcSEcCtD
Doxylamine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000933	0.00236	CcSEcCtD
Doxylamine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000933	0.00236	CcSEcCtD
Doxylamine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000928	0.00235	CcSEcCtD
Doxylamine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000927	0.00235	CcSEcCtD
Doxylamine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000919	0.00233	CcSEcCtD
Doxylamine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000919	0.00233	CcSEcCtD
Doxylamine—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.000917	0.066	CrCbGaD
Doxylamine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.00232	CcSEcCtD
Doxylamine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000917	0.00232	CcSEcCtD
Doxylamine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000914	0.00231	CcSEcCtD
Doxylamine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00091	0.0023	CcSEcCtD
Doxylamine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000904	0.00229	CcSEcCtD
Doxylamine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000898	0.00227	CcSEcCtD
Doxylamine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000896	0.00227	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00089	0.00225	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00089	0.00225	CcSEcCtD
Doxylamine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000889	0.00225	CcSEcCtD
Doxylamine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000889	0.00225	CcSEcCtD
Doxylamine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000882	0.00223	CcSEcCtD
Doxylamine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000882	0.00223	CcSEcCtD
Doxylamine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000881	0.00223	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000872	0.00221	CcSEcCtD
Doxylamine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000871	0.0022	CcSEcCtD
Doxylamine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000868	0.0022	CcSEcCtD
Doxylamine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.00219	CcSEcCtD
Doxylamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000862	0.00218	CcSEcCtD
Doxylamine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000854	0.00216	CcSEcCtD
Doxylamine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000854	0.00216	CcSEcCtD
Doxylamine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00085	0.00215	CcSEcCtD
Doxylamine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00085	0.00215	CcSEcCtD
Doxylamine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000846	0.00214	CcSEcCtD
Doxylamine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000845	0.00214	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000841	0.00213	CcSEcCtD
Doxylamine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00084	0.00212	CcSEcCtD
Doxylamine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000833	0.00211	CcSEcCtD
Doxylamine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000819	0.00207	CcSEcCtD
Doxylamine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000819	0.00207	CcSEcCtD
Doxylamine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000813	0.00206	CcSEcCtD
Doxylamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000812	0.00206	CcSEcCtD
Doxylamine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000806	0.00204	CcSEcCtD
Doxylamine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000805	0.00204	CcSEcCtD
Doxylamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000805	0.00204	CcSEcCtD
Doxylamine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000802	0.00203	CcSEcCtD
Doxylamine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000802	0.00203	CcSEcCtD
Doxylamine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.0008	0.00203	CcSEcCtD
Doxylamine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000788	0.00199	CcSEcCtD
Doxylamine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000782	0.00198	CcSEcCtD
Doxylamine—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000774	0.0557	CrCbGaD
Doxylamine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000774	0.00196	CcSEcCtD
Doxylamine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00076	0.00192	CcSEcCtD
Doxylamine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00076	0.00192	CcSEcCtD
Doxylamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000759	0.00192	CcSEcCtD
Doxylamine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000744	0.00188	CcSEcCtD
Doxylamine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00074	0.00187	CcSEcCtD
Doxylamine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00074	0.00187	CcSEcCtD
Doxylamine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00073	0.00185	CcSEcCtD
Doxylamine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00073	0.00185	CcSEcCtD
Doxylamine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000725	0.00183	CcSEcCtD
Doxylamine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000717	0.00182	CcSEcCtD
Doxylamine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000715	0.00181	CcSEcCtD
Doxylamine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000706	0.00179	CcSEcCtD
Doxylamine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000706	0.00179	CcSEcCtD
Doxylamine—Chlorphenamine—SLC6A4—chronic obstructive pulmonary disease	0.000705	0.0507	CrCbGaD
Doxylamine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.0007	0.00177	CcSEcCtD
Doxylamine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000699	0.00177	CcSEcCtD
Doxylamine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000695	0.00176	CcSEcCtD
Doxylamine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000691	0.00175	CcSEcCtD
Doxylamine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000689	0.00174	CcSEcCtD
Doxylamine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000684	0.00173	CcSEcCtD
Doxylamine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000682	0.00173	CcSEcCtD
Doxylamine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000682	0.00173	CcSEcCtD
Doxylamine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000668	0.00169	CcSEcCtD
Doxylamine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000666	0.00169	CcSEcCtD
Doxylamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000656	0.00166	CcSEcCtD
Doxylamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000656	0.00166	CcSEcCtD
Doxylamine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00065	0.00165	CcSEcCtD
Doxylamine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00065	0.00165	CcSEcCtD
Doxylamine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00065	0.00164	CcSEcCtD
Doxylamine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00065	0.00164	CcSEcCtD
Doxylamine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000644	0.00163	CcSEcCtD
Doxylamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000642	0.00163	CcSEcCtD
Doxylamine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000637	0.00161	CcSEcCtD
Doxylamine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000636	0.00161	CcSEcCtD
Doxylamine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000635	0.00161	CcSEcCtD
Doxylamine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000634	0.00161	CcSEcCtD
Doxylamine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000625	0.00158	CcSEcCtD
Doxylamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.00157	CcSEcCtD
Doxylamine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000617	0.00156	CcSEcCtD
Doxylamine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000615	0.00156	CcSEcCtD
Doxylamine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000614	0.00155	CcSEcCtD
Doxylamine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.00155	CcSEcCtD
Doxylamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000613	0.00155	CcSEcCtD
Doxylamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000613	0.00155	CcSEcCtD
Doxylamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0006	0.00152	CcSEcCtD
Doxylamine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000593	0.0015	CcSEcCtD
Doxylamine—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000592	0.0426	CrCbGaD
Doxylamine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000582	0.00147	CcSEcCtD
Doxylamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000578	0.00146	CcSEcCtD
Doxylamine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000576	0.00146	CcSEcCtD
Doxylamine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000568	0.00144	CcSEcCtD
Doxylamine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000558	0.00141	CcSEcCtD
Doxylamine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000545	0.00138	CcSEcCtD
Doxylamine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00054	0.00137	CcSEcCtD
Doxylamine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000534	0.00135	CcSEcCtD
Doxylamine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00053	0.00134	CcSEcCtD
Doxylamine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000516	0.00131	CcSEcCtD
Doxylamine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000505	0.00128	CcSEcCtD
Doxylamine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000497	0.00126	CcSEcCtD
Doxylamine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	0.000464	0.0334	CrCbGaD
Doxylamine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000461	0.00117	CcSEcCtD
Doxylamine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00046	0.00116	CcSEcCtD
Doxylamine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000457	0.00116	CcSEcCtD
Doxylamine—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	0.000455	0.0328	CrCbGaD
Doxylamine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000454	0.00115	CcSEcCtD
Doxylamine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00114	CcSEcCtD
Doxylamine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000447	0.00113	CcSEcCtD
Doxylamine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000444	0.00112	CcSEcCtD
Doxylamine—Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	0.00044	0.0316	CrCbGaD
Doxylamine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000435	0.0313	CrCbGaD
Doxylamine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000431	0.00109	CcSEcCtD
Doxylamine—Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	0.000424	0.0305	CrCbGaD
Doxylamine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	0.000423	0.0304	CrCbGaD
Doxylamine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000422	0.00107	CcSEcCtD
Doxylamine—Methadone—CYP1A2—chronic obstructive pulmonary disease	0.00042	0.0303	CrCbGaD
Doxylamine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000418	0.00106	CcSEcCtD
Doxylamine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000411	0.00104	CcSEcCtD
Doxylamine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000406	0.00103	CcSEcCtD
Doxylamine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000398	0.00101	CcSEcCtD
Doxylamine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000396	0.001	CcSEcCtD
Doxylamine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000392	0.000993	CcSEcCtD
Doxylamine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000387	0.000979	CcSEcCtD
Doxylamine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000376	0.027	CrCbGaD
Doxylamine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000369	0.000935	CcSEcCtD
Doxylamine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000367	0.000929	CcSEcCtD
Doxylamine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	0.000361	0.026	CrCbGaD
Doxylamine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000359	0.0258	CrCbGaD
Doxylamine—Doxepin—HTR2A—chronic obstructive pulmonary disease	0.000357	0.0257	CrCbGaD
Doxylamine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000353	0.000893	CcSEcCtD
Doxylamine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000352	0.000891	CcSEcCtD
Doxylamine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000352	0.00089	CcSEcCtD
Doxylamine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00035	0.000886	CcSEcCtD
Doxylamine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000878	CcSEcCtD
Doxylamine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000846	CcSEcCtD
Doxylamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.00084	CcSEcCtD
Doxylamine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	0.000329	0.0237	CrCbGaD
Doxylamine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000327	0.0235	CrCbGaD
Doxylamine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000322	0.000816	CcSEcCtD
Doxylamine—Promazine—HTR2A—chronic obstructive pulmonary disease	0.000317	0.0228	CrCbGaD
Doxylamine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000757	CcSEcCtD
Doxylamine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000737	CcSEcCtD
Doxylamine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000287	0.000727	CcSEcCtD
Doxylamine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000703	CcSEcCtD
Doxylamine—Imipramine—HTR2A—chronic obstructive pulmonary disease	0.000277	0.02	CrCbGaD
Doxylamine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	0.000276	0.0199	CrCbGaD
Doxylamine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000679	CcSEcCtD
Doxylamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000653	CcSEcCtD
Doxylamine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000648	CcSEcCtD
Doxylamine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000647	CcSEcCtD
Doxylamine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00061	CcSEcCtD
Doxylamine—Amitriptyline—ALB—chronic obstructive pulmonary disease	0.000189	0.0136	CrCbGaD
